Related Experiment Video
Updated: Jan 9, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease
Karen Lahme1, Wiebke Sachs1, Sarah Froembling1
1Institute of Cellular and Integrative Physiology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany; Hamburg Center for Kidney Health, UKE, 20246 Hamburg, Germany.
Abstract:
Chronic kidney disease affects 1 in 10 people worldwide, with damage to specialized blood filter cells of the kidney, called podocytes, playing a critical role. In membranous nephropathy (MN), a major cause of nephrotic syndrome, circulating autoantibodies attack proteins on podocyte foot processes (FPs), damaging the kidney's filtration barrier. Our study shows that these autoantibodies trigger the formation of antigen-autoantibody aggregates on the podocyte FP plasma membrane. These aggregates bud off as stalked vesicles, termed autoimmunoglobulin-triggered extracellular vesicles (AIT-EVs), which are released into the urine. AIT-EVs carry disease-causing autoantibodies, their target antigens, essential FP proteins, and disease-associated stressors representing a mechanism for removing immune complexes (ICs) and waste. However, their excessive release leads to FP effacement and podocyte dysfunction. In MN patients, urinary AIT-EVs correspond to glomerular urinary-space aggregates. Enriching AIT-EVs enables detection and monitoring of pathogenic autoantibodies, suggesting a non-invasive approach for autoimmune kidney disease diagnosis and therapy.
Insights
Researchers discovered autoimmunoglobulin-triggered extracellular vesicles (AIT-EVs) in urine, which are released by damaged kidney podocytes in membranous nephropathy. These AIT-EVs may offer a new way to diagnose and monitor autoimmune kidney diseases.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Chronic kidney disease impacts 10% of the global population.
- Podocyte damage is central to kidney disease progression.
- Membranous nephropathy (MN) involves autoantibodies attacking kidney podocytes, causing nephrotic syndrome.
Purpose of the Study:
- Investigate the mechanism of podocyte damage in membranous nephropathy.
- Identify urinary biomarkers for autoimmune kidney diseases.
- Explore novel diagnostic and therapeutic strategies for MN.
Main Methods:
- Characterization of autoimmunoglobulin-triggered extracellular vesicles (AIT-EVs) from podocytes.
- Analysis of AIT-EV composition, including autoantibodies, antigens, and podocyte proteins.
- Correlation of urinary AIT-EVs with glomerular pathology in MN patients.
Main Results:
- Autoantibodies attacking podocyte foot processes trigger the formation and release of AIT-EVs.
- AIT-EVs contain pathogenic autoantibodies, target antigens, and essential podocyte proteins.
- Urinary AIT-EVs in MN patients reflect glomerular immune complex aggregates and podocyte damage.
Conclusions:
- AIT-EVs represent a novel mechanism of podocyte injury and waste removal in autoimmune kidney disease.
- Urinary AIT-EVs can be enriched to detect and monitor disease-specific autoantibodies.
- This discovery suggests a potential non-invasive diagnostic and therapeutic approach for membranous nephropathy and other autoimmune kidney diseases.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Nephrotic Syndrome I : Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Cell-mediated Immune Responses

